[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:lung-small-cell-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":309,"states":314},"Lung Small Cell Carcinoma",147,129,[8,16,22,29,36,43,49,55,61,67,73,79,85,91,97,103,109,115,122,128,134,139,144,150,156,162,168,174,180,186,192,198,204,210,216,222,228,234,240,246,252,258,264,270,276,281,287,292,298,303],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06931626","Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer",[12],"Phase 1","RECRUITING","2026-08-26T02:16:34.792807Z","2026-07-30T01:46:14.467928Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT06922539","Phase 1 Trial of ST-001 nanoFenretinide in Relapsed\u002F Refractory Small Cell Lung Cancer",[12],"2026-08-26T02:17:51.502023Z","2026-07-19T19:36:05.058775Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT06780137","A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed\u002FRefractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)",[26],"Phase 1\u002FPhase 2","2026-08-26T02:18:33.598205Z","2026-07-19T19:36:05.056445Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06095505","A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer",[33],"Phase 2","2026-08-26T02:16:11.347936Z","2026-07-05T05:32:16.741897Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":41,"content_modified":42},"NCT06801834","Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer",[40],"Phase 3","2026-08-26T02:17:27.435233Z","2026-06-16T05:54:07.923326Z",{"nct_id":44,"title":45,"phases":46,"status":13,"updated_at":47,"content_modified":48},"NCT07564401","A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy",[26],"2026-08-26T02:16:48.735701Z","2026-05-29T15:36:40.194100Z",{"nct_id":50,"title":51,"phases":52,"status":13,"updated_at":53,"content_modified":54},"NCT07531095","Study of Tarlatamab + ZL-1310 +\u002F- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)",[12],"2026-08-26T02:15:37.042762Z","2026-05-13T02:55:06.720286Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT05903092","MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer",[33],"2026-08-26T02:17:43.321968Z","2026-05-13T02:55:06.393101Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT05450965","Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer",[33],"2026-08-26T02:16:24.970704Z","2026-05-05T02:43:29.734949Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT05419076","A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain",[33],"2026-08-26T02:16:05.813655Z","2026-05-05T02:43:29.712863Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT06424067","Phase 2 Study of Fingolimod in Lung Cancers",[33],"2026-08-26T02:17:11.311767Z","2026-05-05T02:43:29.649841Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT06807632","A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer",[12],"2026-08-26T02:15:21.365312Z","2026-05-05T02:43:29.474959Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT05588388","Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases",[33],"2026-08-26T02:18:41.390601Z","2026-05-05T02:43:29.356266Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT07037758","A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)",[12],"2026-08-26T02:19:31.671303Z","2026-05-05T02:43:29.338212Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT06095583","Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)",[40],"2026-08-03T03:20:00.985008Z","2026-05-05T02:43:29.214508Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT07423585","Tarlatamab for the Treatment of Extensive Stage Small-cell Lung Cancer",[33],"2026-08-26T02:16:56.877406Z","2026-05-05T02:43:29.173230Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT06892548","A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer",[26],"2026-08-26T02:17:05.997056Z","2026-05-05T02:43:29.172171Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":120,"content_modified":121},"NCT04402788","Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial",[119],"Phase 2\u002FPhase 3","2026-08-26T02:17:17.791881Z","2026-05-05T02:43:29.076101Z",{"nct_id":123,"title":124,"phases":125,"status":13,"updated_at":126,"content_modified":127},"NCT07218146","A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)",[40],"2026-08-26T02:15:44.309045Z","2026-05-05T02:43:29.040563Z",{"nct_id":129,"title":130,"phases":131,"status":13,"updated_at":132,"content_modified":133},"NCT07339059","Study of Sacituzumab Govitecan With Atezolizumab\u002FDurvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer",[33],"2026-08-26T02:16:01.910993Z","2026-05-05T02:43:28.826270Z",{"nct_id":135,"title":136,"phases":137,"status":13,"updated_at":41,"content_modified":138},"NCT07149363","Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer",[33],"2026-05-05T02:43:28.736362Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":107,"content_modified":143},"NCT07476287","Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer",[33],"2026-05-05T02:43:28.676699Z",{"nct_id":145,"title":146,"phases":147,"status":13,"updated_at":148,"content_modified":149},"NCT04919382","Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer",[33],"2026-08-26T02:18:23.582895Z","2026-05-05T02:43:28.669905Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT06773910","BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)",[33],"2026-08-26T02:16:07.529922Z","2026-05-05T02:43:28.545727Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":160,"content_modified":161},"NCT06110572","Phase I\u002FII Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation",[26],"2026-08-26T02:17:02.694423Z","2026-05-05T02:43:28.414284Z",{"nct_id":163,"title":164,"phases":165,"status":13,"updated_at":166,"content_modified":167},"NCT07407933","A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors",[26],"2026-08-26T02:17:25.718160Z","2026-05-05T02:43:28.349316Z",{"nct_id":169,"title":170,"phases":171,"status":13,"updated_at":172,"content_modified":173},"NCT07057791","Phase II Study of Platinum\u002FEtoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer",[33],"2026-08-26T02:17:35.666428Z","2026-05-05T02:43:28.336806Z",{"nct_id":175,"title":176,"phases":177,"status":13,"updated_at":178,"content_modified":179},"NCT07459634","A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC",[33],"2026-08-26T02:17:24.721169Z","2026-05-05T02:43:28.291852Z",{"nct_id":181,"title":182,"phases":183,"status":13,"updated_at":184,"content_modified":185},"NCT06681220","Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC",[26],"2026-08-26T02:15:30.699880Z","2026-05-05T02:43:28.221131Z",{"nct_id":187,"title":188,"phases":189,"status":13,"updated_at":190,"content_modified":191},"NCT06203210","A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer",[40],"2026-08-26T02:19:23.493898Z","2026-05-05T02:43:28.187890Z",{"nct_id":193,"title":194,"phases":195,"status":13,"updated_at":196,"content_modified":197},"NCT06103682","LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)",[],"2026-08-26T02:15:41.377360Z","2026-05-05T02:43:28.186344Z",{"nct_id":199,"title":200,"phases":201,"status":13,"updated_at":202,"content_modified":203},"NCT06769126","Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study",[33],"2026-08-26T02:16:52.995882Z","2026-05-05T02:43:28.175325Z",{"nct_id":205,"title":206,"phases":207,"status":13,"updated_at":208,"content_modified":209},"NCT07155174","A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer",[33],"2026-08-26T02:18:36.226508Z","2026-05-05T02:43:27.843204Z",{"nct_id":211,"title":212,"phases":213,"status":13,"updated_at":214,"content_modified":215},"NCT07226999","Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer",[119],"2026-08-26T02:15:49.658025Z","2026-05-05T02:43:27.815560Z",{"nct_id":217,"title":218,"phases":219,"status":13,"updated_at":220,"content_modified":221},"NCT07113691","Iadademstat + SBRT With Atezo in ES-SCLC",[12],"2026-08-26T02:19:20.945539Z","2026-05-05T02:43:27.804765Z",{"nct_id":223,"title":224,"phases":225,"status":13,"updated_at":226,"content_modified":227},"NCT07153055","Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer",[26],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:27.769230Z",{"nct_id":229,"title":230,"phases":231,"status":13,"updated_at":232,"content_modified":233},"NCT04696575","Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer",[33],"2026-08-26T02:18:39.640967Z","2026-05-05T02:43:27.754887Z",{"nct_id":235,"title":236,"phases":237,"status":13,"updated_at":238,"content_modified":239},"NCT05578326","Study of Trilaciclib and Lurbinectidin",[33],"2026-08-26T02:18:18.766496Z","2026-05-05T02:43:27.643317Z",{"nct_id":241,"title":242,"phases":243,"status":13,"updated_at":244,"content_modified":245},"NCT06592638","A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer",[12],"2026-08-26T02:15:26.669629Z","2026-05-05T02:43:27.643282Z",{"nct_id":247,"title":248,"phases":249,"status":13,"updated_at":250,"content_modified":251},"NCT06646276","A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).",[40],"2026-08-26T02:17:57.997171Z","2026-05-05T02:43:27.639365Z",{"nct_id":253,"title":254,"phases":255,"status":13,"updated_at":256,"content_modified":257},"NCT06712355","Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer",[40],"2026-08-26T02:18:38.865010Z","2026-05-05T02:43:27.489792Z",{"nct_id":259,"title":260,"phases":261,"status":13,"updated_at":262,"content_modified":263},"NCT07545954","DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer",[12],"2026-08-26T02:17:18.747857Z","2026-05-05T02:43:27.277013Z",{"nct_id":265,"title":266,"phases":267,"status":13,"updated_at":268,"content_modified":269},"NCT06362252","A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)",[26],"2026-08-26T02:17:04.346841Z","2026-05-05T02:43:27.255171Z",{"nct_id":271,"title":272,"phases":273,"status":13,"updated_at":274,"content_modified":275},"NCT07227597","A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)",[26],"2026-08-26T02:17:46.653867Z","2026-05-05T02:43:27.091454Z",{"nct_id":277,"title":278,"phases":279,"status":13,"updated_at":250,"content_modified":280},"NCT05244239","Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer",[12],"2026-05-05T02:43:26.958680Z",{"nct_id":282,"title":283,"phases":284,"status":13,"updated_at":285,"content_modified":286},"NCT04342429","Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer",[],"2026-08-26T02:18:01.700186Z","2026-05-05T02:43:26.750768Z",{"nct_id":288,"title":289,"phases":290,"status":13,"updated_at":238,"content_modified":291},"NCT07472517","DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy",[40],"2026-05-05T02:43:26.721153Z",{"nct_id":293,"title":294,"phases":295,"status":13,"updated_at":296,"content_modified":297},"NCT07155200","Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)",[26],"2026-08-26T02:19:10.436356Z","2026-05-05T02:43:26.710423Z",{"nct_id":299,"title":300,"phases":301,"status":13,"updated_at":53,"content_modified":302},"NCT06179069","A Study of ZL-1310 in Subjects With Small Cell Lung Cancer",[12],"2026-05-05T02:35:31.914744Z",{"nct_id":304,"title":305,"phases":306,"status":13,"updated_at":307,"content_modified":308},"NCT06287775","Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer",[26],"2026-08-26T02:18:27.904411Z","2026-05-05T02:35:31.683658Z",[310],{"biomarker":311,"count":312,"slug":313},"DLL3 Gene",8,"dll3-gene",[315,319,323,327,331,335,339,343,346,349,353,357,361,364,368,372,375,379,383,387,390,394,398,401],{"state":316,"count":317,"slug":318},"Texas",60,"texas",{"state":320,"count":321,"slug":322},"California",58,"california",{"state":324,"count":325,"slug":326},"Florida",50,"florida",{"state":328,"count":329,"slug":330},"New York",48,"new-york",{"state":332,"count":333,"slug":334},"Virginia",44,"virginia",{"state":336,"count":337,"slug":338},"Ohio",42,"ohio",{"state":340,"count":341,"slug":342},"Massachusetts",37,"massachusetts",{"state":344,"count":341,"slug":345},"Michigan","michigan",{"state":347,"count":341,"slug":348},"Tennessee","tennessee",{"state":350,"count":351,"slug":352},"Illinois",33,"illinois",{"state":354,"count":355,"slug":356},"Missouri",32,"missouri",{"state":358,"count":359,"slug":360},"Maryland",30,"maryland",{"state":362,"count":359,"slug":363},"New Jersey","new-jersey",{"state":365,"count":366,"slug":367},"Pennsylvania",29,"pennsylvania",{"state":369,"count":370,"slug":371},"Colorado",27,"colorado",{"state":373,"count":370,"slug":374},"Kentucky","kentucky",{"state":376,"count":377,"slug":378},"Georgia",25,"georgia",{"state":380,"count":381,"slug":382},"Indiana",24,"indiana",{"state":384,"count":385,"slug":386},"North Carolina",22,"north-carolina",{"state":388,"count":385,"slug":389},"Washington","washington",{"state":391,"count":392,"slug":393},"Arizona",21,"arizona",{"state":395,"count":396,"slug":397},"Connecticut",19,"connecticut",{"state":399,"count":396,"slug":400},"Minnesota","minnesota",{"state":402,"count":403,"slug":404},"Wisconsin",16,"wisconsin"]